Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.

Author: CorriganMargaret, JonesDavid, JopsonLaura, KhannaAmardeep, PetersonPatricia, RudellElaine

Paper Details 
Original Abstract of the Article :
Primary Biliary Cholangitis (PBC, formerly cirrhosis), is a chronic cholestatic liver disease which until spring 2016 had a single licensed therapy, Ursodeoxycholic acid (UDCA). Approximately 30% of patients do not respond to UDCA, and are high-risk for progressing to end stage liver disease, transp...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s10620-018-5074-8

データ提供:米国国立医学図書館(NLM)

Stratified Therapy for Primary Biliary Cholangitis: Are Clinicians Ready?

Navigating the complex terrain of liver diseases can be challenging for both patients and clinicians. Primary biliary cholangitis (PBC) is a chronic liver disease that can progress to end-stage liver disease, liver transplantation, or even death. While there have been advances in treating PBC, such as the development of new second-line therapies, there are concerns about clinicians' readiness to use these new treatment options effectively and safely. The authors of this abstract aimed to assess clinicians' knowledge and awareness of stratified therapy for PBC.

Understanding Stratified Therapy for PBC

Stratified therapy is a personalized approach to treatment that takes into account individual patient characteristics, such as their risk factors and response to previous therapies. This approach allows for more targeted treatment options that may be more effective and safer than traditional one-size-fits-all approaches. The authors of this abstract studied clinicians' knowledge and awareness of stratified therapy for PBC. Their findings revealed that many clinicians lacked the necessary knowledge and expertise to appropriately implement second-line therapies for PBC.

Implications for Patients

This study highlights the importance of continued education and training for clinicians who treat patients with PBC. Patients with PBC should be aware of the importance of working with clinicians who are knowledgeable about stratified therapy and who are committed to providing personalized treatment.

Dr.Camel's Conclusion

This study is a reminder that the desert of medical knowledge is vast, and there is always more to learn. Clinicians must continually update their knowledge and skills to effectively treat patients with complex conditions like PBC. Patients, in turn, should be active partners in their own healthcare and seek out clinicians who are well-informed and committed to providing personalized care.

Date :
  1. Date Completed 2019-04-09
  2. Date Revised 2022-01-29
Further Info :

Pubmed ID

29736833

DOI: Digital Object Identifier

10.1007/s10620-018-5074-8

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.